$6.89
-0.1-1.43%
At Close: -
$6.89
00.00%
After Hours: Jul 19, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Agilon Health
AGLNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Agilon Health (NYSE:AGL) Stock, Analyst Ratings, Price Targets, Forecasts
Agilon Health Inc has a consensus price target of $16 based on the ratings of 21 analysts. The high is $44 issued by Cowen & Co. on September 10, 2021. The low is $5 issued by Barclays on March 6, 2024. The 3 most-recent analyst ratings were released by Evercore ISI Group, Baird, and Truist Securities on July 9, 2024, May 30, 2024, and May 24, 2024, respectively. With an average price target of $6.5 between Evercore ISI Group, Baird, and Truist Securities, there's an implied -5.66% downside for Agilon Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Evercore ISI Group
Baird
Truist Securities
Stifel
Citigroup
1calculated from analyst ratings
Analyst Ratings for Agilon Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | Buy Now | 1.6% | Evercore ISI Group | Elizabeth Anderson | $5.5 → $7 | Maintains | In-Line | Get Alert |
| 05/30/2024 | Buy Now | -12.92% | Baird | Michael Halloran | → $6 | Initiates | → Neutral | Get Alert |
| 05/24/2024 | Buy Now | -5.66% | Truist Securities | Jailendra Singh | $6.4 → $6.5 | Maintains | Hold | Get Alert |
| 05/01/2024 | Buy Now | 1.6% | Stifel | Craig Jones | $8 → $7 | Maintains | Hold | Get Alert |
| 04/22/2024 | Buy Now | -12.92% | Citigroup | Daniel Grosslight | → $6 | Initiates | → Neutral | Get Alert |
| 04/15/2024 | Buy Now | -7.11% | Truist Securities | Jailendra Singh | $7.5 → $6.4 | Maintains | Hold | Get Alert |
| 03/06/2024 | Buy Now | -27.43% | Barclays | Andrew Mok | → $5 | Initiates | → Underweight | Get Alert |
| 02/29/2024 | Buy Now | 8.85% | Truist Securities | Jailendra Singh | $10 → $7.5 | Maintains | Hold | Get Alert |
| 02/29/2024 | Buy Now | 30.62% | Benchmark | Bill Sutherland | $13 → $9 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | -12.92% | Evercore ISI Group | Elizabeth Anderson | $7 → $6 | Maintains | In-Line | Get Alert |
| 02/28/2024 | Buy Now | 16.11% | RBC Capital | Sean Dodge | $11 → $8 | Maintains | Outperform | Get Alert |
| 02/26/2024 | Buy Now | -5.66% | TD Cowen | Gary Taylor | $12 → $6.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/22/2024 | Buy Now | 30.62% | Stifel | Craig Jones | $10 → $9 | Maintains | Hold | Get Alert |
| 01/08/2024 | Buy Now | — | Wolfe Research | Justin Lake | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 01/05/2024 | Buy Now | 45.14% | Truist Securities | Jailendra Singh | $23 → $10 | Downgrade | Buy → Hold | Get Alert |
| 01/05/2024 | Buy Now | 30.62% | JP Morgan | Lisa Gill | $17 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 12/11/2023 | Buy Now | — | Goldman Sachs | Jamie Perse | — | Downgrade | Buy → Neutral | Get Alert |
| 12/06/2023 | Buy Now | 161.25% | JMP Securities | Constantine Davides | → $18 | Initiates | → Market Outperform | Get Alert |
| 11/21/2023 | Buy Now | 74.17% | Deutsche Bank | George Hill | $27 → $12 | Downgrade | Buy → Hold | Get Alert |
| 11/15/2023 | Buy Now | 219.3% | Benchmark | Bill Sutherland | $28 → $22 | Maintains | Buy | Get Alert |
| 11/13/2023 | Buy Now | 132.22% | Wells Fargo | Stephen Baxter | $23 → $16 | Maintains | Overweight | Get Alert |
| 11/09/2023 | Buy Now | 233.82% | Truist Securities | Jailendra Singh | $27 → $23 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | 219.3% | Goldman Sachs | Jamie Perse | $25 → $22 | Maintains | Buy | Get Alert |
| 11/03/2023 | Buy Now | 233.82% | RBC Capital | Sean Dodge | $28 → $23 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | 306.39% | Benchmark | Bill Sutherland | → $28 | Initiates | → Buy | Get Alert |
| 08/15/2023 | Buy Now | 262.84% | Goldman Sachs | Jamie Perse | $29 → $25 | Maintains | Buy | Get Alert |
| 08/15/2023 | Buy Now | 262.84% | TD Cowen | Gary Taylor | $29 → $25 | Maintains | Outperform | Get Alert |
| 06/20/2023 | Buy Now | 291.87% | Truist Securities | Jailendra Singh | $35 → $27 | Maintains | Buy | Get Alert |
| 06/13/2023 | Buy Now | 226.56% | Evercore ISI Group | Elizabeth Anderson | → $22.5 | Initiates | → In-Line | Get Alert |
| 05/31/2023 | Buy Now | 320.9% | Goldman Sachs | Jamie Perse | $32 → $29 | Maintains | Buy | Get Alert |
| 05/15/2023 | Buy Now | 291.87% | Deutsche Bank | George Hill | $28 → $27 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 378.96% | RBC Capital | Sean Dodge | → $33 | Reiterates | → Outperform | Get Alert |
| 05/10/2023 | Buy Now | 364.44% | Stifel | Craig Jones | $29 → $20 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 407.98% | Truist Securities | Jailendra Singh | $29 → $35 | Maintains | Buy | Get Alert |
| 03/06/2023 | Buy Now | 335.41% | Guggenheim | Sandy Draper | $21 → $30 | Maintains | Buy | Get Alert |
| 03/03/2023 | Buy Now | 306.39% | Deutsche Bank | George Hill | $26 → $28 | Maintains | Buy | Get Alert |
| 12/09/2022 | Buy Now | 233.82% | Stifel | Craig Jones | → $23 | Initiates | → Buy | Get Alert |
| 11/15/2022 | Buy Now | 393.47% | Goldman Sachs | Jamie Perse | $38 → $34 | Maintains | Buy | Get Alert |
| 11/15/2022 | Buy Now | 219.3% | Wells Fargo | Stephen Baxter | $28 → $22 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | 335.41% | SVB Leerink | Whit Mayo | $33 → $30 | Maintains | Outperform | Get Alert |
| 09/14/2022 | Buy Now | 378.96% | RBC Capital | Sean Dodge | → $33 | Initiates | → Outperform | Get Alert |
| 09/12/2022 | Buy Now | 451.52% | Goldman Sachs | Jamie Perse | → $38 | Initiates | → Buy | Get Alert |
| 09/07/2022 | Buy Now | 320.9% | Truist Securities | Jailendra Singh | $33 → $29 | Assumes | → Buy | Get Alert |
| 08/08/2022 | Buy Now | 306.39% | Wells Fargo | Stephen Baxter | $23 → $28 | Maintains | Overweight | Get Alert |
| 08/03/2022 | Buy Now | 335.41% | Deutsche Bank | George Hill | $29 → $30 | Maintains | Buy | Get Alert |
| 07/14/2022 | Buy Now | 378.96% | Truist Securities | David Macdonald | $30 → $33 | Maintains | Buy | Get Alert |
| 06/24/2022 | Buy Now | — | BTIG | David Larsen | — | Initiates | → Neutral | Get Alert |
| 06/08/2022 | Buy Now | 277.36% | Deutsche Bank | George Hill | $26 → $26 | Maintains | Buy | Get Alert |
| 05/10/2022 | Buy Now | 277.36% | Deutsche Bank | George Hill | → $26 | Maintains | Buy | Get Alert |
| 03/31/2022 | Buy Now | 378.96% | SVB Leerink | Whit Mayo | $25 → $33 | Maintains | Outperform | Get Alert |
| 03/30/2022 | Buy Now | 364.44% | Guggenheim | Sandy Draper | → $32 | Initiates | → Buy | Get Alert |
| 03/15/2022 | Buy Now | 262.84% | SVB Leerink | Whit Mayo | $35 → $25 | Maintains | Outperform | Get Alert |
| 03/06/2022 | Buy Now | 335.41% | Deutsche Bank | George Hill | $29 → $30 | Maintains | Buy | Get Alert |
| 01/25/2022 | Buy Now | 320.9% | Deutsche Bank | George Hill | $30 → $29 | Maintains | Buy | Get Alert |
| 12/14/2021 | Buy Now | 335.41% | Deutsche Bank | George Hill | — | Maintains | Buy | Get Alert |
| 11/03/2021 | Buy Now | 422.5% | Deutsche Bank | George Hill | $44 → $36 | Maintains | Buy | Get Alert |
| 11/01/2021 | Buy Now | 407.98% | SVB Leerink | Whit Mayo | — | Maintains | Outperform | Get Alert |
| 10/20/2021 | Buy Now | 407.98% | Jefferies | Brian Tanquilut | — | Initiates | → Buy | Get Alert |
| 09/27/2021 | Buy Now | 437.01% | SVB Leerink | Whit Mayo | — | Initiates | → Outperform | Get Alert |
| 09/10/2021 | Buy Now | 538.61% | Cowen & Co. | Gary Taylor | — | Initiates | → Outperform | Get Alert |
| 08/06/2021 | Buy Now | 538.61% | Deutsche Bank | George Hill | $45 → $44 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Agilon Health (AGL) stock?
The latest price target for Agilon Health (NYSE:AGL) was reported by Evercore ISI Group on July 9, 2024. The analyst firm set a price target for $7.00 expecting AGL to rise to within 12 months (a possible 1.60% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Agilon Health (AGL)?
The latest analyst rating for Agilon Health (NYSE:AGL) was provided by Evercore ISI Group, and Agilon Health maintained their in-line rating.
When was the last upgrade for Agilon Health (AGL)?
There is no last upgrade for Agilon Health
When was the last downgrade for Agilon Health (AGL)?
The last downgrade for Agilon Health Inc happened on February 26, 2024 when TD Cowen changed their price target from $12 to $6.5 for Agilon Health Inc.
When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on July 9, 2024 so you should expect the next rating to be made available sometime around July 9, 2025.
Is the Analyst Rating Agilon Health (AGL) correct?
While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $5.50 to $7.00. The current price Agilon Health (AGL) is trading at is $6.89, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.